Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Science ; 372(6548): 1314-1318, 2021 06 18.
Article in English | MEDLINE | ID: mdl-34016741

ABSTRACT

In heterogeneous catalysis research, the reactivity of individual nanofacets of single particles is typically not resolved. We applied in situ field electron microscopy to the apex of a curved rhodium crystal (radius of 650 nanometers), providing high spatial (~2 nanometers) and time resolution (~2 milliseconds) of oscillatory catalytic hydrogen oxidation, to image adsorbed species and reaction fronts on the individual facets. Using ionized water as the imaging species, the active sites were directly imaged with field ion microscopy. The catalytic behavior of differently structured nanofacets and the extent of coupling between them were monitored individually. We observed limited interfacet coupling, entrainment, frequency locking, and reconstruction-induced collapse of spatial coupling. The experimental results are backed up by microkinetic modeling of time-dependent oxygen species coverages and oscillation frequencies.

2.
Catal Letters ; 146(10): 1867-1874, 2016.
Article in English | MEDLINE | ID: mdl-32355436

ABSTRACT

ABSTRACT: The catalytic H2 oxidation reaction on stepped Rh surfaces in the 10-6 mbar pressure range was studied in situ on individual high-Miller-index domains of a polycrystalline Rh foil by PEEM (photoemission electron microscopy) and on a Rh nanotip by FIM/FEM (field-ion/field-emission microscopy). The activity, particularly the tolerance to poisoning by oxygen, was found to strongly depend on the density of steps and defects, as well as on the size of the catalytically active surfaces.

3.
Ultramicroscopy ; 159 Pt 2: 147-51, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25766998

ABSTRACT

An improved methodology of the Zr specimen preparation was developed which allows fabrication of stable Zr nanotips suitable for FIM and AP applications. Initial oxidation of the Zr surface was studied on a Zr nanotip by FIM and on a polycrystalline Zr foil by XPS, both at low oxygen pressure (10(-8)-10(-7)mbar). The XPS data reveal that in a first, fast stage of oxidation, a Zr suboxide interlayer is formed which contains three suboxide components (Zr(+1), Zr(+2) and Zr(+3)) and is located between the Zr surface and a stoichiometric ZrO2 overlayer that grows in a second, slow oxidation stage. The sole suboxide layer has been observed for the first time at very early states of the oxidation (oxygen exposure ≤ 4L). The Ne(+) FIM observations are in accord with a two stage process of Zr oxide formation.

4.
Vox Sang ; 78 Suppl 2: 257-9, 2000.
Article in English | MEDLINE | ID: mdl-10938964

ABSTRACT

BACKGROUND AND OBJECTIVES: Nucleic acid testing was introduced at our blood transfusion service in order to reduce the diagnostic preseroconversion window for transfusion relevant viruses. MATERIALS AND METHODS: Up to 96 donor samples were pooled overnight by two Tecan Genesis RSP 150 pipettors. Pools were centrifuged at 48,000 g for one hour to enrich viruses. Viral nucleic acids were extracted from centrifugation pellets using modified Qiagen viral RNA kit. HIV and HBV sequences were amplified by in house TaqMan PCR's with patented primers and probes for HBV. HCV PCR was performed by Roche Amplicor V2.0. "Nadis" software was developed for pooling, resolving positive pools and data communication with main frame computer. RESULTS: PCR testing was introduced in January 1997 for HCV HBV and HIV-1 for all plasma products and for labile components at the 21st of April 1997. Throughput increased from 2000 to 4000 samples per day. PCR testing is done in parallel to serological testing and products are released eight hours after pooling is completed. Until January 2000, 1,078,940 donations have been tested in 13,274 pools. A total of seven PCR only positives were identified (3 HCV, 3 HBV, 1 HIV). CONCLUSION: The yield of PCR testing for transfusion relevant viruses confirms theoretical estimates on the residual risk of antibody screening.


Subject(s)
Blood Transfusion/standards , Nucleic Acid Amplification Techniques , Blood Donors , Consumer Product Safety , DNA, Viral/blood , Humans , Polymerase Chain Reaction , RNA, Viral/blood , Serologic Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...